AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26408012
Drug: High-dose intensity-modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intensity-modulated radiation therapy (IMRT) combined with androgen deprivation therapy (ADT) for 6 months
Trial: 16206677
Drug: Oxymatrine (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymatrine (intravenous or intra-muscular injection and oral capsule)
Trial: 9872196
Drug: Salbutamol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (200 microg by metered‐dose inhaler)
Trial: 7884169
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (tripotassium dicitrato bismuthate 125 mg q.i.d., tetracycline hydrochloride 500 mg q.i.d., metronidazole 500 mg t.i.d.)
Trial: 344157
Drug: Cimetidine 300
RxNorm normalized name: cimetidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 300 mg four times daily
Trial: 25120315
Drug: Sirolimus (SRL)
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus (SRL) conversion from calcineurin inhibitors (CNI)
Trial: 23194491
Drug: Paricalcitol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paricalcitol (2 μg oral)
Trial: 20184605
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) for grass pollen; specific details on dosage and duration not provided.
Trial: 20184605
Drug: Placebo treatment;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment; specific details on dosage and duration not provided.
Trial: 15785883
Drug: Cefoxitin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (100 mg) added to Tisseel-VH fibrin sealant
Trial: 15785883
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Cefoxitin + Surgical closure)
Trial: 14728086
Drug: Oral ziprasidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ziprasidone
Trial: 10532523
Drug: Nitroglycerin lingual
RxNorm normalized name: Nitroglycerin Lingual Spray
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin lingual spray
Trial: 10532523
Drug: Nitroglycerin sublingual
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin sublingual tablet
Trial: 1909749
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (TN)
Trial: 1909749
Drug: Long-acting oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting oral nitrates (LAON)
Trial: 3859027
Drug: Preventive measures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive measures focused on oral hygiene and/or fluorides
Trial: 31118485
Drug: 3-month intervention
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month intervention involving a face-to-face meeting (medication review and consumer-centred video) and health coaching every two weeks
Trial: 27416546
Drug: Topical furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical furosemide (300 µg per day, 2 puffs twice a day for 2 months)
Trial: 20493474
Drug: 17β‐E2 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17β‐E2 1 mg/drospirenone 2 mg
Trial: 20493474
Drug: 17β‐E2 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17β‐E2 1 mg/norethisterone acetate 0.5 mg
Trial: 15616757
Drug: I.M. testovirone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I.M. testovirone depot 100 mg monthly for 6 months
Trial: 15616757
Drug: Oxandrolone 5
RxNorm normalized name: Oxandrolone
DrugBank: Oxandrolone (DB00621)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxandrolone 5 mg/m2 daily for 6 months
Trial: 10941955
Drug: Feedback on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feedback on asthma treatment
Trial: 10941955
Drug: Feedback on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feedback on UTI treatment
Trial: 8814852
Drug: Sexual-hormone binding
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sexual-hormone binding globulin (SHBG)
Trial: 12512664
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no early treatment)
Trial: 9082830
Drug: Microvessel count
RxNorm normalized name: oteseconazole
DrugBank: Oteseconazole (DB13055)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Microvessel count (MC) assessed using JC70 monoclonal antibody (CD31)
Trial: 1796618
Drug: Prednisolone-pulse-therapy
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone-pulse-therapy
Trial: 6828842
Drug: Acetazolamide (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (2 X 250 mg)
Trial: 6828842
Drug: Long-term Acetazolamide
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term Acetazolamide therapy
Trial: 26254255
Drug: rTMS combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTMS combined with comprehensive rehabilitation therapy
Trial: 26254255
Drug: Sham therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham therapy combined with comprehensive rehabilitation therapy
Trial: 18251624
Drug: Olanzapine (2.5-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (2.5-15 mg/day)
Trial: 11008913
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HPV and LSIL cutpoint
Trial: 3884297
Drug: Injection sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection sclerotherapy with phenol (N = 62)
Trial: 24155093
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (SB) supplementation at 0.3 g/kg body mass
Trial: 18408607
Drug: CHO (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO (0.8 g.kg(‐1)h(‐1) of carbohydrate)
Trial: 18408607
Drug: CHO‐PRO (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO‐PRO (0.8 g.kg(‐1)h(‐1) of carbohydrate + 0.3 g.kg(‐1)h(‐1) of whey protein isolate)
Trial: 16161728
Drug: Levo‐alpha‐acetylmethadol (LAAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levo‐alpha‐acetylmethadol (LAAM) treatment
Trial: 16161728
Drug: Community treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community treatment referral information only (Control)
Trial: 16161728
Drug: Withdrawn from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawn from treatment (Control)
Trial: 8777484
Drug: Chronic oral
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic oral administration of propafenone
Trial: 3294945
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil 2% solution applied twice daily with UVB treatment
Trial: 3294945
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil 2% solution applied twice daily with PUVA treatment
Trial: 3294945
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil 2% solution applied twice daily without UVL
Trial: 29649309
Drug: Lopinavir/ritonavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir monotherapy (MT)
Trial: 24041682
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of daily living (3 bouts of 15 min, ∼3 METs)
Trial: 17531401
Drug: Whole pelvic
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole pelvic radiotherapy (WPRT) + Neoadjuvant hormonal therapy (NHT)
Trial: 17531401
Drug: Prostate only
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate only radiotherapy (PORT) + Neoadjuvant hormonal therapy (NHT)
Trial: 17531401
Drug: Whole pelvic
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole pelvic radiotherapy (WPRT) + Adjuvant hormonal therapy (AHT)
Trial: 17531401
Drug: Prostate only
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate only radiotherapy (PORT) + Adjuvant hormonal therapy (AHT)
Trial: 17531401
Drug: Neoadjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neoadjuvant hormonal therapy (NHT) + Radiotherapy (RT)
Trial: 10901187
Drug: Urinary thymidine
RxNorm normalized name: Thymidine
DrugBank: Thymidine (DB04485)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary thymidine glycol excretion after kidney transplantation
Trial: 10901187
Drug: Gel-electrophoretic pattern
RxNorm normalized name: benzocaine
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gel-electrophoretic pattern of proteinuria
Trial: 10901187
Drug: Thymidine glycol
RxNorm normalized name: Thymidine
DrugBank: Thymidine (DB04485)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymidine glycol excretion levels during different phases
Trial: 2694860
Drug: Suction on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suction on the tubes with a 60‐ml syringe
Trial: 15760
Drug: Beta-adrenoreceptor antagonists
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenoreceptor antagonists (specific drugs not mentioned)
Trial: 31398157
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous fluids before surgery (study group, 90 patients)
Trial: 31398157
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml crystalline intravenous fluids one hour before anaesthesia (control group, 90 patients)
Trial: 23814850
Drug: R-CHOP (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP (standard treatment)
Trial: 20633187
Drug: Rabeprazole-based quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole-based quadruple rescue therapies (RB)
Trial: 20633187
Drug: Esomeprazole-based quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole-based quadruple rescue therapies (EB)
Trial: 6994783
Drug: Guanfacine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine 1.0 mg and 2.0 mg
Trial: 6994783
Drug: Clonidine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.15 mg and 0.3 mg
Trial: 30650500
Drug: Alendronate sodium
RxNorm normalized name: Alendronate Sodium
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate sodium 70 mg each week
Trial: 25085304
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (Transbond XT; 3M Unitek)
Trial: 19557208
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg once daily added to ICS or ICS/LABA therapy
Trial: 18372683
Drug: Intermittent artificial
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent artificial gravity (AG) via short radius centrifugation (SRC) for 60 min daily during bed rest
Trial: 12059822
Drug: Midazolam 0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.02 mg.kg(‐1)
Trial: 12059822
Drug: Propofol 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.25 mg.kg(‐1)
Trial: 8583658
Drug: Amrinone 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone 0.5 mg.kg‐1 administered in the venous reservoir near the end of cardiopulmonary bypass (CPB) and doses of 1 and 5 micrograms.kg‐1.min‐1 by intravenous infusion
Trial: 6268475
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (21 g/day in three divided doses at main meals)
Trial: 27560946
Drug: HCP0911 (fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCP0911 (fixed-dose combination of clopidogrel and aspirin)
Trial: 27560946
Drug: Separate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate treatment with daily 75 mg clopidogrel plus 100 mg aspirin
Trial: 22617861
Drug: Atomoxetine (ATX)
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine (ATX) at a target dose of 1.2 mg/kg per day
Trial: 12440843
Drug: Anthroposophical herbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthroposophical herbal remedy (20 drops 4 times daily for 4 weeks)
Trial: 2373128
Drug: Org 3770
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 3770 (30 mg)
Trial: 22551440
Drug: Adjuvant doxorubicin-based
RxNorm normalized name: Rna-based adjuvant cv8102
DrugBank: CV-8102 (DB19184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant doxorubicin-based chemotherapy with or without docetaxel
Trial: 9678794
Drug: G-CSF 6
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF 6 microg/kg/12 h
Trial: 9678794
Drug: G-CSF 8
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF 8 microg/kg/12 h
Trial: 30279273
Drug: Urinary DKK3-to-creatinine
RxNorm normalized name: Creatinine
DrugBank: Creatinine (DB11846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary DKK3-to-creatinine level >4000 pg/mg
Trial: 26580997
Drug: ALS-008176 (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALS-008176 (750 mg loading dose followed by 500 mg maintenance doses)
Trial: 26580997
Drug: ALS-008176 (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALS-008176 (750 mg loading dose followed by 150 mg maintenance doses)
Trial: 26580997
Drug: ALS-008176 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALS-008176 (10 doses of 375 mg)
Trial: 26580997
Drug: ALS-008176 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALS-008176 (all groups with loading dose)
Trial: 20622695
Drug: Lipostabil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipostabil (0.5 ml injected in one eyelid)
Trial: 20622695
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline (0.5 ml injected in the opposite eyelid)
Trial: 18461520
Drug: 5-aminosalicylates (sulphasalazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-aminosalicylates (sulphasalazine 2 g/d)
Trial: 18461520
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition at home
Trial: 10595624
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg per day)
Trial: 8919898
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg eltanolone
Trial: 8919898
Drug: 0.75 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg/kg eltanolone
Trial: 8919898
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg eltanolone
Trial: 8919898
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg thiopentone
Trial: 1812137
Drug: L-tryptophan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan (50 mg/kg of body weight)
Trial: 6305758
Drug: Intravenous corticotropin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous corticotropin (120 U/day)
Trial: 6305758
Drug: Intravenous hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous hydrocortisone (300 mg/day)
Trial: 30658605
Drug: IV infusion
RxNorm normalized name: IV INFUSION SET (WINTHROP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV infusion of 10 IU oxytocin
Trial: 30658605
Drug: IM injection
RxNorm normalized name: filgrastim Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM injection of 10 IU oxytocin
Trial: 26672898
Drug: Dabigatran (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran (150 mg twice-daily)
Trial: 26672898
Drug: Dabigatran (110
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran (110 mg twice-daily)
Trial: 26672898
Drug: Rivaroxaban (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban (20 mg once-daily)
Trial: 26672898
Drug: Rivaroxaban (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban (15 mg once-daily)
Trial: 26672898
Drug: Apixaban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban (5 mg twice-daily)
Trial: 26672898
Drug: Apixaban (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban (2.5 mg twice-daily)
Trial: 22549097
Drug: Dispersible levodopa/carbidopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible levodopa/carbidopa microtablets (LC-5), 5/1.25 mg
Trial: 22549097
Drug: Standard levodopa/carbidopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard levodopa/carbidopa (LC-100), 100/25 mg
Trial: 22549097
Drug: Dispersible levodopa/benserazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible levodopa/benserazide (LB-100), 100/25 mg
Trial: 22549097
Drug: Carbidopa (from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbidopa (from all formulations)
Trial: 22549097
Drug: 3-O-MD (from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-O-MD (from all formulations)
Trial: 10761164
Drug: Effervescent acetaminophen
RxNorm normalized name: acetaminophen Effervescent Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effervescent acetaminophen 1000 mg
Trial: 10761164
Drug: Tablet acetaminophen
RxNorm normalized name: acetaminophen Chewable Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet acetaminophen 1000 mg
Trial: 10761164
Drug: Both acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both acetaminophen formulations
Trial: 9204788
Drug: Preoperative acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative acetaminophen (15 mg/kg oral)
Trial: 9204788
Drug: Postoperative acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative acetaminophen (20 mg/kg rectal)
Trial: 31023524
Drug: Metronomic capecitabine
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Metronomic capecitabine (625 mg/m2 twice per day) with cyclophosphamide (50 mg/d)
Trial: 26270199
Drug: HeProCalc program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HeProCalc program for heparin and protamine dosing
Trial: 26270199
Drug: Traditional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional heparin and protamine dosing based on body weight
Trial: 24618345
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (spinal manipulation, spinal mobilization, stretching and massage)
Trial: 24618345
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy excluding spinal manipulation
Trial: 24618345
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy excluding stretching
Trial: 24618345
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (all groups)
Trial: 20571294
Drug: Dexamethasone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (4 mg IV before anesthesia)
Trial: 20571294
Drug: Ketolgan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketolgan (30 mg IV before anesthesia)
Trial: 8719981
Drug: Perfusion scintigraphy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perfusion scintigraphy in combination with ventilation studies
Trial: 30935375
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of nonavalent HPV vaccine (GARDASIL 9)
Trial: 24150660
Drug: Combination acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination acetaminophen (48 mg·kg(‐1)·day(‐1)) and ibuprofen (24 mg·kg(‐1)·day(‐1))
Trial: 24150660
Drug: Acetaminophen alone
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen alone (48 mg·kg(‐1)·day(‐1))